EMEA (Europe, Middle East and Africa) Prostate Cancer Diagnostics Market Report 2017

October 2017 | 118 pages | ID: E7D11ABD02DPEN
QYResearch

Abstracts

In this report, the EMEA Prostate Cancer Diagnostics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Prostate Cancer Diagnostics for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Prostate Cancer Diagnostics market competition by top manufacturers/players, with Prostate Cancer Diagnostics sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Genomic Health
• Abbott
• OPKO
• Siemens Healthcare
• DiaSorin
• bioMeriux
• Roche
• MDx Health
• Beckman Coulter
• Myriad Genetics
• Ambry Genetics

On the basis of product, this report displays the sales volume (K Pcs), revenue (Million USD), product price (USD/Pcs), market share and growth rate of each type, primarily split into

• Tumor Biomarker Tests
• Imaging
• Biopsy
• Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Pcs), market share and growth rate of Prostate Cancer Diagnostics for each application, including

• Under 55 Years Old
• 55-75 Years Old
• Above 75 Years Old

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Prostate Cancer Diagnostics Market Report 2017

1 PROSTATE CANCER DIAGNOSTICS OVERVIEW

1.1 Product Overview and Scope of Prostate Cancer Diagnostics
1.2 Classification of Prostate Cancer Diagnostics
  1.2.1 EMEA Prostate Cancer Diagnostics Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Prostate Cancer Diagnostics Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Tumor Biomarker Tests
  1.2.4 Imaging
  1.2.5 Biopsy
  1.2.6 Other
1.3 EMEA Prostate Cancer Diagnostics Market by Application/End Users
  1.3.1 EMEA Prostate Cancer Diagnostics Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Under 55 Years Old
  1.3.3 55-75 Years Old
  1.3.4 Above 75 Years Old
1.4 EMEA Prostate Cancer Diagnostics Market by Region
  1.4.1 EMEA Prostate Cancer Diagnostics Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Prostate Cancer Diagnostics (2012-2022)
  1.5.1 EMEA Prostate Cancer Diagnostics Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Prostate Cancer Diagnostics Revenue and Growth Rate (2012-2022)

2 EMEA PROSTATE CANCER DIAGNOSTICS COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Prostate Cancer Diagnostics Market Competition by Players/Manufacturers
  2.1.1 EMEA Prostate Cancer Diagnostics Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Prostate Cancer Diagnostics Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Prostate Cancer Diagnostics Sale Price by Players (2012-2017)
2.2 EMEA Prostate Cancer Diagnostics (Volume and Value) by Type/Product Category
  2.2.1 EMEA Prostate Cancer Diagnostics Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Prostate Cancer Diagnostics Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Prostate Cancer Diagnostics Sale Price by Type (2012-2017)
2.3 EMEA Prostate Cancer Diagnostics (Volume) by Application
2.4 EMEA Prostate Cancer Diagnostics (Volume and Value) by Region
  2.4.1 EMEA Prostate Cancer Diagnostics Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Prostate Cancer Diagnostics Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Prostate Cancer Diagnostics Sales Price by Region (2012-2017)

3 EUROPE PROSTATE CANCER DIAGNOSTICS (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Prostate Cancer Diagnostics Sales and Value (2012-2017)
  3.1.1 Europe Prostate Cancer Diagnostics Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Prostate Cancer Diagnostics Revenue and Growth Rate (2012-2017)
3.2 Europe Prostate Cancer Diagnostics Sales and Market Share by Type
3.3 Europe Prostate Cancer Diagnostics Sales and Market Share by Application
3.4 Europe Prostate Cancer Diagnostics Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Prostate Cancer Diagnostics Sales Volume by Countries (2012-2017)
  3.4.2 Europe Prostate Cancer Diagnostics Revenue by Countries (2012-2017)
  3.4.3 Germany Prostate Cancer Diagnostics Sales and Growth Rate (2012-2017)
  3.4.4 France Prostate Cancer Diagnostics Sales and Growth Rate (2012-2017)
  3.4.5 UK Prostate Cancer Diagnostics Sales and Growth Rate (2012-2017)
  3.4.6 Russia Prostate Cancer Diagnostics Sales and Growth Rate (2012-2017)
  3.4.7 Italy Prostate Cancer Diagnostics Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Prostate Cancer Diagnostics Sales and Growth Rate (2012-2017)

4 MIDDLE EAST PROSTATE CANCER DIAGNOSTICS (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Prostate Cancer Diagnostics Sales and Value (2012-2017)
  4.1.1 Middle East Prostate Cancer Diagnostics Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Prostate Cancer Diagnostics Revenue and Growth Rate (2012-2017)
4.2 Middle East Prostate Cancer Diagnostics Sales and Market Share by Type
4.3 Middle East Prostate Cancer Diagnostics Sales and Market Share by Application
4.4 Middle East Prostate Cancer Diagnostics Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Prostate Cancer Diagnostics Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Prostate Cancer Diagnostics Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Prostate Cancer Diagnostics Sales and Growth Rate (2012-2017)
  4.4.4 Israel Prostate Cancer Diagnostics Sales and Growth Rate (2012-2017)
  4.4.5 UAE Prostate Cancer Diagnostics Sales and Growth Rate (2012-2017)
  4.4.6 Iran Prostate Cancer Diagnostics Sales and Growth Rate (2012-2017)

5 AFRICA PROSTATE CANCER DIAGNOSTICS (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Prostate Cancer Diagnostics Sales and Value (2012-2017)
  5.1.1 Africa Prostate Cancer Diagnostics Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Prostate Cancer Diagnostics Revenue and Growth Rate (2012-2017)
5.2 Africa Prostate Cancer Diagnostics Sales and Market Share by Type
5.3 Africa Prostate Cancer Diagnostics Sales and Market Share by Application
5.4 Africa Prostate Cancer Diagnostics Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Prostate Cancer Diagnostics Sales Volume by Countries (2012-2017)
  5.4.2 Africa Prostate Cancer Diagnostics Revenue by Countries (2012-2017)
  5.4.3 South Africa Prostate Cancer Diagnostics Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Prostate Cancer Diagnostics Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Prostate Cancer Diagnostics Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Prostate Cancer Diagnostics Sales and Growth Rate (2012-2017)

6 EMEA PROSTATE CANCER DIAGNOSTICS MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Genomic Health
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Prostate Cancer Diagnostics Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Genomic Health Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Abbott
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Prostate Cancer Diagnostics Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Abbott Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 OPKO
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Prostate Cancer Diagnostics Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 OPKO Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Siemens Healthcare
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Prostate Cancer Diagnostics Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Siemens Healthcare Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 DiaSorin
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Prostate Cancer Diagnostics Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 DiaSorin Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 bioMeriux
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Prostate Cancer Diagnostics Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 bioMeriux Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Roche
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Prostate Cancer Diagnostics Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Roche Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 MDx Health
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Prostate Cancer Diagnostics Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 MDx Health Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Beckman Coulter
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Prostate Cancer Diagnostics Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Beckman Coulter Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Myriad Genetics
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Prostate Cancer Diagnostics Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Myriad Genetics Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Ambry Genetics

7 PROSTATE CANCER DIAGNOSTICS MANUFACTURING COST ANALYSIS

7.1 Prostate Cancer Diagnostics Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Prostate Cancer Diagnostics

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Prostate Cancer Diagnostics Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Prostate Cancer Diagnostics Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA PROSTATE CANCER DIAGNOSTICS MARKET FORECAST (2017-2022)

11.1 EMEA Prostate Cancer Diagnostics Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Prostate Cancer Diagnostics Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Prostate Cancer Diagnostics Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Prostate Cancer Diagnostics Price and Trend Forecast (2017-2022)
11.2 EMEA Prostate Cancer Diagnostics Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Prostate Cancer Diagnostics Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Prostate Cancer Diagnostics Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Prostate Cancer Diagnostics Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Prostate Cancer Diagnostics Sales Forecast by Type (2017-2022)
11.7 EMEA Prostate Cancer Diagnostics Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Prostate Cancer Diagnostics
Figure EMEA Prostate Cancer Diagnostics Sales Volume (K Pcs) by Type (2012-2022)
Figure EMEA Prostate Cancer Diagnostics Sales Volume Market Share by Type (Product Category) in 2016
Figure Tumor Biomarker Tests Product Picture
Figure Imaging Product Picture
Figure Biopsy Product Picture
Figure Other Product Picture
Figure EMEA Prostate Cancer Diagnostics Sales Volume (K Pcs) by Application (2012-2022)
Figure EMEA Sales Market Share of Prostate Cancer Diagnostics by Application in 2016
Figure Under 55 Years Old Examples
Table Key Downstream Customer in Under 55 Years Old
Figure 55-75 Years Old Examples
Table Key Downstream Customer in 55-75 Years Old
Figure Above 75 Years Old Examples
Table Key Downstream Customer in Above 75 Years Old
Figure EMEA Prostate Cancer Diagnostics Market Size (Million USD) by Region (2012-2022)
Figure Europe Prostate Cancer Diagnostics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Prostate Cancer Diagnostics Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Prostate Cancer Diagnostics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Prostate Cancer Diagnostics Revenue (Million USD) Status and Forecast by Countries
Figure Africa Prostate Cancer Diagnostics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Prostate Cancer Diagnostics Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Prostate Cancer Diagnostics Sales Volume and Growth Rate (2012-2022)
Figure EMEA Prostate Cancer Diagnostics Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Prostate Cancer Diagnostics Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table EMEA Prostate Cancer Diagnostics Sales Volume (K Pcs) of Major Players (2012-2017)
Table EMEA Prostate Cancer Diagnostics Sales Share by Players (2012-2017)
Figure 2016 Prostate Cancer Diagnostics Sales Share by Players
Figure 2017 Prostate Cancer Diagnostics Sales Share by Players
Figure EMEA Prostate Cancer Diagnostics Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Prostate Cancer Diagnostics Revenue (Million USD) by Players (2012-2017)
Table EMEA Prostate Cancer Diagnostics Revenue Share by Players (2012-2017)
Table 2016 EMEA Prostate Cancer Diagnostics Revenue Share by Players
Table 2017 EMEA Prostate Cancer Diagnostics Revenue Share by Players
Table EMEA Prostate Cancer Diagnostics Sale Price (USD/Pcs) by Players (2012-2017)
Table EMEA Prostate Cancer Diagnostics Sales (K Pcs) and Market Share by Type (2012-2017)
Table EMEA Prostate Cancer Diagnostics Sales Share by Type (2012-2017)
Figure Sales Market Share of Prostate Cancer Diagnostics by Type (2012-2017)
Figure EMEA Prostate Cancer Diagnostics Sales Market Share by Type (2012-2017)
Table EMEA Prostate Cancer Diagnostics Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Prostate Cancer Diagnostics Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Prostate Cancer Diagnostics by Type in 2016
Table EMEA Prostate Cancer Diagnostics Sale Price (USD/Pcs) by Type (2012-2017)
Table EMEA Prostate Cancer Diagnostics Sales (K Pcs) and Market Share by Application (2012-2017)
Table EMEA Prostate Cancer Diagnostics Sales Share by Application (2012-2017)
Figure Sales Market Share of Prostate Cancer Diagnostics by Application (2012-2017)
Figure EMEA Prostate Cancer Diagnostics Sales Market Share by Application in 2016
Table EMEA Prostate Cancer Diagnostics Sales (K Pcs) and Market Share by Region (2012-2017)
Table EMEA Prostate Cancer Diagnostics Sales Share by Region (2012-2017)
Figure Sales Market Share of Prostate Cancer Diagnostics by Region (2012-2017)
Figure EMEA Prostate Cancer Diagnostics Sales Market Share in 2016
Table EMEA Prostate Cancer Diagnostics Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Prostate Cancer Diagnostics Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Prostate Cancer Diagnostics by Region (2012-2017)
Figure EMEA Prostate Cancer Diagnostics Revenue Market Share Regions in 2016
Table EMEA Prostate Cancer Diagnostics Sales Price (USD/Pcs) by Region (2012-2017)
Figure Europe Prostate Cancer Diagnostics Sales (K Pcs) and Growth Rate (2012-2017)
Figure Europe Prostate Cancer Diagnostics Revenue and Growth Rate (2012-2017)
Table Europe Prostate Cancer Diagnostics Sales (K Pcs) by Type (2012-2017)
Table Europe Prostate Cancer Diagnostics Market Share by Type (2012-2017)
Figure Europe Prostate Cancer Diagnostics Market Share by Type in 2016
Table Europe Prostate Cancer Diagnostics Sales (K Pcs) by Application (2012-2017)
Table Europe Prostate Cancer Diagnostics Market Share by Application (2012-2017)
Figure Europe Prostate Cancer Diagnostics Market Share by Application in 2016
Table Europe Prostate Cancer Diagnostics Sales (K Pcs) by Countries (2012-2017)
Table Europe Prostate Cancer Diagnostics Sales Market Share by Countries (2012-2017)
Figure Europe Prostate Cancer Diagnostics Sales Market Share by Countries (2012-2017)
Figure Europe Prostate Cancer Diagnostics Sales Market Share by Countries in 2016
Table Europe Prostate Cancer Diagnostics Revenue (Million USD) by Countries (2012-2017)
Table Europe Prostate Cancer Diagnostics Revenue Market Share by Countries (2012-2017)
Figure Europe Prostate Cancer Diagnostics Revenue Market Share by Countries (2012-2017)
Figure Europe Prostate Cancer Diagnostics Revenue Market Share by Countries in 2016
Figure Germany Prostate Cancer Diagnostics Sales (K Pcs) and Growth Rate (2012-2017)
Figure France Prostate Cancer Diagnostics Sales (K Pcs) and Growth Rate (2012-2017)
Figure UK Prostate Cancer Diagnostics Sales (K Pcs) and Growth Rate (2012-2017)
Figure Russia Prostate Cancer Diagnostics Sales (K Pcs) and Growth Rate (2012-2017)
Figure Italy Prostate Cancer Diagnostics Sales (K Pcs) and Growth Rate (2012-2017)
Figure Benelux Prostate Cancer Diagnostics Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Prostate Cancer Diagnostics Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Prostate Cancer Diagnostics Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Prostate Cancer Diagnostics Sales (K Pcs) by Type (2012-2017)
Table Middle East Prostate Cancer Diagnostics Market Share by Type (2012-2017)
Figure Middle East Prostate Cancer Diagnostics Market Share by Type (2012-2017)
Table Middle East Prostate Cancer Diagnostics Sales (K Pcs) by Applications (2012-2017)
Table Middle East Prostate Cancer Diagnostics Market Share by Applications (2012-2017)
Figure Middle East Prostate Cancer Diagnostics Sales Market Share by Application in 2016
Table Middle East Prostate Cancer Diagnostics Sales Volume (K Pcs) by Countries (2012-2017)
Table Middle East Prostate Cancer Diagnostics Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Prostate Cancer Diagnostics Sales Volume Market Share by Countries in 2016
Table Middle East Prostate Cancer Diagnostics Revenue (Million USD) by Countries (2012-2017)
Table Middle East Prostate Cancer Diagnostics Revenue Market Share by Countries (2012-2017)
Figure Middle East Prostate Cancer Diagnostics Revenue Market Share by Countries (2012-2017)
Figure Middle East Prostate Cancer Diagnostics Revenue Market Share by Countries in 2016
Figure Saudi Arabia Prostate Cancer Diagnostics Sales (K Pcs) and Growth Rate (2012-2017)
Figure Israel Prostate Cancer Diagnostics Sales (K Pcs) and Growth Rate (2012-2017)
Figure UAE Prostate Cancer Diagnostics Sales (K Pcs) and Growth Rate (2012-2017)
Figure Iran Prostate Cancer Diagnostics Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Prostate Cancer Diagnostics Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Prostate Cancer Diagnostics Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Prostate Cancer Diagnostics Sales (K Pcs) by Type (2012-2017)
Table Africa Prostate Cancer Diagnostics Sales Market Share by Type (2012-2017)
Figure Africa Prostate Cancer Diagnostics Sales Market Share by Type (2012-2017)
Figure Africa Prostate Cancer Diagnostics Sales Market Share by Type in 2016
Table Africa Prostate Cancer Diagnostics Sales (K Pcs) by Application (2012-2017)
Table Africa Prostate Cancer Diagnostics Sales Market Share by Application (2012-2017)
Figure Africa Prostate Cancer Diagnostics Sales Market Share by Application (2012-2017)
Table Africa Prostate Cancer Diagnostics Sales Volume (K Pcs) by Countries (2012-2017)
Table Africa Prostate Cancer Diagnostics Sales Market Share by Countries (2012-2017)
Figure Africa Prostate Cancer Diagnostics Sales Market Share by Countries (2012-2017)
Figure Africa Prostate Cancer Diagnostics Sales Market Share by Countries in 2016
Table Africa Prostate Cancer Diagnostics Revenue (Million USD) by Countries (2012-2017)
Table Africa Prostate Cancer Diagnostics Revenue Market Share by Countries (2012-2017)
Figure Africa Prostate Cancer Diagnostics Revenue Market Share by Countries (2012-2017)
Figure Africa Prostate Cancer Diagnostics Revenue Market Share by Countries in 2016
Figure South Africa Prostate Cancer Diagnostics Sales (K Pcs) and Growth Rate (2012-2017)
Figure Nigeria Prostate Cancer Diagnostics Sales (K Pcs) and Growth Rate (2012-2017)
Figure Egypt Prostate Cancer Diagnostics Sales (K Pcs) and Growth Rate (2012-2017)
Figure Algeria Prostate Cancer Diagnostics Sales (K Pcs) and Growth Rate (2012-2017)
Table Genomic Health Prostate Cancer Diagnostics Basic Information List
Table Genomic Health Prostate Cancer Diagnostics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Genomic Health Prostate Cancer Diagnostics Sales (K Pcs) and Growth Rate (2012-2017)
Figure Genomic Health Prostate Cancer Diagnostics Sales Market Share in EMEA (2012-2017)
Figure Genomic Health Prostate Cancer Diagnostics Revenue Market Share in EMEA (2012-2017)
Table Abbott Prostate Cancer Diagnostics Basic Information List
Table Abbott Prostate Cancer Diagnostics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Abbott Prostate Cancer Diagnostics Sales (K Pcs) and Growth Rate (2012-2017)
Figure Abbott Prostate Cancer Diagnostics Sales Market Share in EMEA (2012-2017)
Figure Abbott Prostate Cancer Diagnostics Revenue Market Share in EMEA (2012-2017)
Table OPKO Prostate Cancer Diagnostics Basic Information List
Table OPKO Prostate Cancer Diagnostics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure OPKO Prostate Cancer Diagnostics Sales (K Pcs) and Growth Rate (2012-2017)
Figure OPKO Prostate Cancer Diagnostics Sales Market Share in EMEA (2012-2017)
Figure OPKO Prostate Cancer Diagnostics Revenue Market Share in EMEA (2012-2017)
Table Siemens Healthcare Prostate Cancer Diagnostics Basic Information List
Table Siemens Healthcare Prostate Cancer Diagnostics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Siemens Healthcare Prostate Cancer Diagnostics Sales (K Pcs) and Growth Rate (2012-2017)
Figure Siemens Healthcare Prostate Cancer Diagnostics Sales Market Share in EMEA (2012-2017)
Figure Siemens Healthcare Prostate Cancer Diagnostics Revenue Market Share in EMEA (2012-2017)
Table DiaSorin Prostate Cancer Diagnostics Basic Information List
Table DiaSorin Prostate Cancer Diagnostics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure DiaSorin Prostate Cancer Diagnostics Sales (K Pcs) and Growth Rate (2012-2017)
Figure DiaSorin Prostate Cancer Diagnostics Sales Market Share in EMEA (2012-2017)
Figure DiaSorin Prostate Cancer Diagnostics Revenue Market Share in EMEA (2012-2017)
Table bioMeriux Prostate Cancer Diagnostics Basic Information List
Table bioMeriux Prostate Cancer Diagnostics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure bioMeriux Prostate Cancer Diagnostics Sales (K Pcs) and Growth Rate (2012-2017)
Figure bioMeriux Prostate Cancer Diagnostics Sales Market Share in EMEA (2012-2017)
Figure bioMeriux Prostate Cancer Diagnostics Revenue Market Share in EMEA (2012-2017)
Table Roche Prostate Cancer Diagnostics Basic Information List
Table Roche Prostate Cancer Diagnostics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Roche Prostate Cancer Diagnostics Sales (K Pcs) and Growth Rate (2012-2017)
Figure Roche Prostate Cancer Diagnostics Sales Market Share in EMEA (2012-2017)
Figure Roche Prostate Cancer Diagnostics Revenue Market Share in EMEA (2012-2017)
Table MDx Health Prostate Cancer Diagnostics Basic Information List
Table MDx Health Prostate Cancer Diagnostics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure MDx Health Prostate Cancer Diagnostics Sales (K Pcs) and Growth Rate (2012-2017)
Figure MDx Health Prostate Cancer Diagnostics Sales Market Share in EMEA (2012-2017)
Figure MDx Health Prostate Cancer Diagnostics Revenue Market Share in EMEA (2012-2017)
Table Beckman Coulter Prostate Cancer Diagnostics Basic Information List
Table Beckman Coulter Prostate Cancer Diagnostics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Beckman Coulter Prostate Cancer Diagnostics Sales (K Pcs) and Growth Rate (2012-2017)
Figure Beckman Coulter Prostate Cancer Diagnostics Sales Market Share in EMEA (2012-2017)
Figure Beckman Coulter Prostate Cancer Diagnostics Revenue Market Share in EMEA (2012-2017)
Table Myriad Genetics Prostate Cancer Diagnostics Basic Information List
Table Myriad Genetics Prostate Cancer Diagnostics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Myriad Genetics Prostate Cancer Diagnostics Sales (K Pcs) and Growth Rate (2012-2017)
Figure Myriad Genetics Prostate Cancer Diagnostics Sales Market Share in EMEA (2012-2017)
Figure Myriad Genetics Prostate Cancer Diagnostics Revenue Market Share in EMEA (2012-2017)
Table Ambry Genetics Prostate Cancer Diagnostics Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Prostate Cancer Diagnostics
Figure Manufacturing Process Analysis of Prostate Cancer Diagnostics
Figure Prostate Cancer Diagnostics Industrial Chain Analysis
Table Raw Materials Sources of Prostate Cancer Diagnostics Major Manufacturers in 2016
Table Major Buyers of Prostate Cancer Diagnostics
Table Distributors/Traders List
Figure EMEA Prostate Cancer Diagnostics Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure EMEA Prostate Cancer Diagnostics Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Prostate Cancer Diagnostics Price (USD/Pcs) and Trend Forecast (2017-2022)
Table EMEA Prostate Cancer Diagnostics Sales (K Pcs) Forecast by Region (2017-2022)
Figure EMEA Prostate Cancer Diagnostics Sales Market Share Forecast by Region (2017-2022)
Table EMEA Prostate Cancer Diagnostics Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Prostate Cancer Diagnostics Revenue Market Share Forecast by Region (2017-2022)
Table Europe Prostate Cancer Diagnostics Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Europe Prostate Cancer Diagnostics Sales Market Share Forecast by Countries (2017-2022)
Table Europe Prostate Cancer Diagnostics Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Prostate Cancer Diagnostics Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Prostate Cancer Diagnostics Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Middle East Prostate Cancer Diagnostics Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Prostate Cancer Diagnostics Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Prostate Cancer Diagnostics Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Prostate Cancer Diagnostics Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Africa Prostate Cancer Diagnostics Sales Market Share Forecast by Countries (2017-2022)
Table Africa Prostate Cancer Diagnostics Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Prostate Cancer Diagnostics Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Prostate Cancer Diagnostics Sales (K Pcs) Forecast by Type (2017-2022)
Figure EMEA Prostate Cancer Diagnostics Sales Market Share Forecast by Type (2017-2022)
Table EMEA Prostate Cancer Diagnostics Sales (K Pcs) Forecast by Application (2017-2022)
Figure EMEA Prostate Cancer Diagnostics Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources